Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Cross-Indication Pricing Implications With GLP-1 therapies spanning multiple indications, cross-indication pricing poses a strategic challenge
27, reporters Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are saying about the health risks and benefits and how it will change the pharmaceutical industry in the country
The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation
Can BodyTone help after GLP-1 weight loss
Find articles by Wheeler, M
(2017) Exenatide once weekly versus placebo in Parkinsons disease: A randomised, double-blind, placebo-controlled trial
US$ 27.57
US$ 29.81
US$ 27.69
US$ 28.93
